Search Results
152 items found for "cancer immune checkpoints"
- 📰 GPCR Weekly News, September 11 to 17, 2023
Kevin Wright on his new position as Director of Targeted and Immuno-oncology at GPCR Therapeutics, our the signaling pathway of miR-19a/GRK6/GPCRs/PKC in a Chinese population Identification of S1PR4 as an immune Kevin Wright Joins GPCR Therapeutics as Director of Targeted and Immuno-oncology Sosei Heptares Adds
- Exscientia is 10 years old this July!
platform clinically validated to guide treatment selection in patients with advanced haematological cancers
- Activation of the human chemokine receptor CX3CR1 regulated by cholesterol
endogenous ligand CX3CL1, which shows notable potential as a therapeutic target in atherosclerosis, cancer
- N-Acyl Amides from Neisseria meningitidis and Their Role in Sphingosine Receptor Signaling
The molecular mechanisms N. meningitidis employ to manipulate the immune system, translocate the mucosal
- 📰 GPCR Weekly News, May 6 to 12, 2024
Chakit Arora, J Silvio Gutkind, and Francesco Raimondi for their work on The landscape of cancer-rewired protein-coupled receptor 141 expressed in myeloid cells functions as an inflammation suppressor The landscape of cancer-rewired neutrophil biology: inflammation, resolution and beyond Exploring GPCR signaling pathway networks as cancer
- GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for...
receptor (A2AAR) have been considered promising agents to treat Parkinson's disease, inflammation, cancer
- 📰 GPCR Weekly News, June 5 to 11, 2023
Autocrine Proteinase-Activated Receptor (PAR) signaling in PC3 prostate cancer cells. GPCRs in Immunology and Oncology The GPCR–Gαs–PKA signaling axis promotes T cell dysfunction and cancer
- Therapeutic validation of an orphan G protein‐coupled receptor
GPR84 is a Gi‐coupled class A GPCR mainly expressed in immune cells and microglia in the brain (Wojciechowicz Regarding the first question, GPR84 overexpression in immune cells in a range of pro‐inflammatory disorders
- 📰 GPCR Weekly News, February 6 to 12, 2023
An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer Structure pulls off rare IPO, raising $161M 3-drug combo leads to 'unprecedented' response in pancreatic cancer
- Focusing on the role of secretin/adhesion (Class B) G protein-coupled receptors in placental...
placentation, uteroplacental malperfusion, oxidative stress, endoplasmic reticulum stress, dysregulated immune
- Mechanistic Understanding of the Palmitoylation of Go Protein in the Allosteric Regulation of...
receptors (aGPCRs)-a major family of GPCRs-play critical roles in the regulation of tissue development and cancer
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
For example, chemotherapy, a powerful standard approach to kill fast-growing cancer cells, has the drawback
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
is a classical G-protein-coupled receptor (GPCR), whereas C5aR2 is a nonclassical GPCR that tailors immune
- 📰 GPCR Weekly News, March 6 to 12, 2023
GPCRs in Oncology and Immunology GPR176 Promotes Cancer Progression by Interacting with G Protein GNAS to Restrain Cell Mitophagy in Colorectal Cancer.
- 📰 GPCR Weekly News, October 16 to 22, 2023
manipulation, and potential use of Opn5 and its homologs Industry News The Leading GPCR Company in Immuno-Oncology reinforces consistent reduction in risk of recurrence across key subgroups of patients with early breast cancer
- Induced Human Regulatory T Cells Express the Glucagon-like Peptide-1 Receptor
experimental animals have shown that certain subsets of T cells express functional GLP-1R, indicating an immune
- GPR15 expressed in T lymphocytes from RA patients is involved in leukocyte chemotaxis to the...
chemotaxis to the synovium "The rheumatoid arthritis (RA) inflammatory process occurs in the joints where immune
- Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...
Through gene expression analysis in immune and gastrointestinal cells, we show that these isoforms emerge
- 📰 GPCR Weekly News, April 10 to 16, 2023
4256, a Highly Potent and Selective Inhibitor of GPR65, in Presentation at American Association for Cancer GPCR Jobs NEW Director - Targeted Oncology NEW Senior Scientist - Antibody Engineering NEW Scientist—Immuno-Oncology
- 📰 GPCR Weekly News, May 29 to June 4, 2023
GPCRs in Oncology and Immunology A2aR on lung adenocarcinoma cells: A novel target for cancer therapy Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
mouse neutrophils Mechanistic exploration of bioactive constituents in Gnetum gnemon for GPCR-related cancer treatment through network pharmacology and molecular docking The Effect of Cancer-Associated Mutations
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Nominated for Prestigious Prix Galien USA ‘Best Startup’ Award: Pioneering GPCR-Driven Immunotherapies in Cancer future directions Going rogue: mechanisms, regulation, and roles of mutationally activated Gα in human cancer
- Odorant G protein-coupled receptors as potential therapeutic targets for adult diffuse gliomas ...
from odor perception, and may contribute to the pathogenesis of disorders including brain diseases and cancers
- Structural dynamics of Smoothened (SMO) in ciliary membrane and its interaction with membrane lipids
signaling pathway, which is involved in embryonic development and is implicated in various types of cancer
- Deficiency of β-arrestin2 alleviates apoptosis through GRP78-ATF6-CHOP signaling pathway in ...
and internalization of G protein-coupled receptors (GPCRs) and it participates in inflammatory and immune
- 📰 GPCR Weekly News, July 3 to 9, 2023
Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
For instance, aberrant endosomal signaling by GPCRs has been linked to disorders such as cancer, neurodegenerative GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic
- 📰 GPCR Weekly News - January 2 to 8, 2023
GPCRs in Oncology and Immunology Vasoactive intestinal peptide receptor 2 signaling promotes breast cancer